Company intelligence / Profile preview
Shorla Oncology
Clonmel, Irelandshorlaoncology.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Commercial
01
Overview
Shorla Oncology has achieved US FDA approval for several innovative oral liquid formulations of established cancer therapies. Its portfolio includes IMKELDI®—the first oral liquid imatinib for leukemia and GIST—and Jylamvo®, an oral methotrexate solution for leukemia, lymphoma, autoimmune diseases, and severe psoriasis. Nelarabine Injection was also approved to address shortages in treatment options for pediatric T-cell leukemias. The company focuses on orphan/pediatric cancers with unmet needs or drug shortages. Clinical results have led to regulatory approvals and commercial launches in the US market since late 2023 through early/mid–2025[2][4][5].
- Therapeutic areas
- OncologyImmunologyHematology
- Modalities
- Small molecules (notably oral liquid formulations of established oncology drugs)[2][6]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
EVERSANA – commercialization services partner in the US; specialty pharmacy distribution partnership for IMKELDI Patient Assistance Program[2].Therakind Ltd – partnered/acquired Jylamvo rights from Therakind Ltd UK for US commercialization[6].
Beyond the preview
Go deeper on Shorla Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shorla Oncology.